Profile: Daxor Corp (DXR)

DXR on American Stock Exchange

8.12USD
17 Apr 2015
Change (% chg)

$-0.22 (-2.64%)
Prev Close
$8.34
Open
$8.17
Day's High
$8.37
Day's Low
$8.03
Volume
12,168
Avg. Vol
39,343
52-wk High
$9.18
52-wk Low
$5.40

Search Stocks

Daxor Corporation, incorporated on May 5, 1971, is a medical instrumentation and biotechnology company. The Company designed and developed the BVA-100 Blood Volume Analyzer. BVA-100 Blood Volume Analyzer provides direct measurement of a patient's blood volume. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. The BVA-100 can measure blood volume in approximately 1.5 hours. In an emergency, preliminary results can be obtained within half an hour. In addition to measuring a patient’s blood volume, the BVA-100 also determines each individual patient’s normal blood volume and compares the measured volume to that patient’s norm. The BVA-100 is used to diagnose and treat patients with heart failure, kidney failure, hypertension and syncope, and to aid in fluid and blood transfusion management. The BVA-100 has also been used to aid in the diagnosis and treatment of disorders of red blood cell volume including polycythemia and anemia, and to aid in pre-surgical evaluation of red blood cell volume.

The Company’s IDANT division (IDANT Laboratories subsidiary) provides semen banking services, which include anonymous donor semen and semen storage, autologous blood storage, andrology services, which include semen analysis and sperm washing, and general lab testing. The Company’s IDANT Blood Bank provides autologous blood banking, which means storing the patient’s blood in a frozen state for use by the patient at a later date in case the patient requires a blood transfusion.

Company Address

Daxor Corp

Suite 7120, 350 Fifth Ave.
NEW YORK   NY   10118
P: +1212.2440555
F: +1212.2440806

Company Web Links

Search Stocks